ESPR
Esperion·NASDAQ
--
--(--)
--
--(--)
4.41 / 10
Netural
Fundamental analysis of Esperion Therapeutics reveals a mixed picture: key profitability metrics such as Interest Coverage Ratio and Profit-MV score well, yet Total and Operating Revenue YoY growth rates are negative, and Days Sales Outstanding is elevated. This combination suggests that while the company is managing its costs and capital structure reasonably, top-line pressure and slow receivable collection remain headwinds. The overall fundamental score of 4.4/10 aligns with a neutral stance, indicating balanced but not strong fundamentals.
Analysis Checks(6/10)
Revenue-MV
Value0.08
Score2/3
Weight15.46%
1M Return7.73%
Value0.08
Score2/3
Weight15.46%
1M Return7.73%
Days sales outstanding
Value114.54
Score0/3
Weight-6.98%
1M Return-5.18%
Value114.54
Score0/3
Weight-6.98%
1M Return-5.18%
Net income-Revenue
Value-0.17
Score2/3
Weight15.76%
1M Return8.45%
Value-0.17
Score2/3
Weight15.76%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.58%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.58%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight29.20%
1M Return13.15%
Value-0.50
Score3/3
Weight29.20%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value-10.83
Score1/3
Weight-1.15%
1M Return-0.79%
Value-10.83
Score1/3
Weight-1.15%
1M Return-0.79%
Profit-MV
Value0.46
Score2/3
Weight15.75%
1M Return8.45%
Value0.46
Score2/3
Weight15.75%
1M Return8.45%
PB-ROE
Value0.39
Score1/3
Weight19.17%
1M Return9.57%
Value0.39
Score1/3
Weight19.17%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value-10.83
Score1/3
Weight-1.11%
1M Return-0.76%
Value-10.83
Score1/3
Weight-1.11%
1M Return-0.76%
Cash-MV
Value-0.07
Score2/3
Weight15.48%
1M Return8.41%
Value-0.07
Score2/3
Weight15.48%
1M Return8.41%
Revenue-MV
Value0.08
Score2/3
Weight15.46%
1M Return7.73%
Value0.08
Score2/3
Weight15.46%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value-10.83
Score1/3
Weight-1.15%
1M Return-0.79%
Value-10.83
Score1/3
Weight-1.15%
1M Return-0.79%
Days sales outstanding
Value114.54
Score0/3
Weight-6.98%
1M Return-5.18%
Value114.54
Score0/3
Weight-6.98%
1M Return-5.18%
Profit-MV
Value0.46
Score2/3
Weight15.75%
1M Return8.45%
Value0.46
Score2/3
Weight15.75%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight15.76%
1M Return8.45%
Value-0.17
Score2/3
Weight15.76%
1M Return8.45%
PB-ROE
Value0.39
Score1/3
Weight19.17%
1M Return9.57%
Value0.39
Score1/3
Weight19.17%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.58%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.58%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-10.83
Score1/3
Weight-1.11%
1M Return-0.76%
Value-10.83
Score1/3
Weight-1.11%
1M Return-0.76%
Asset-MV
Value-0.50
Score3/3
Weight29.20%
1M Return13.15%
Value-0.50
Score3/3
Weight29.20%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight15.48%
1M Return8.41%
Value-0.07
Score2/3
Weight15.48%
1M Return8.41%
Is ESPR fundamentally strong?
- ESPR scores 4.41/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -34.84% net margin, -7.81 P/E ratio, -1.80 P/B ratio, and 19.40% earnings growth, these metrics solidify its Netural investment rating.
